Daily News Podcast

Novel plasma biomarkers for Alzheimer’s

Publish date: February 8, 2019

 

A plasma proteomic study has identified new biomarkers for Alzheimer’s disease pathology in cognitively unimpaired individuals. Also today, biomarkers predict VTE risk with menopausal oral hormone therapy, there is a cloud of inconsistency hanging over cannabis data, and compounded pain creams are no better than placebo for chronic localized pain.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

President Trump calls for end to HIV/AIDS, pediatric cancer
MDedge Endocrinology
Biomarkers predict VTE risk with menopausal oral hormone therapy
MDedge Endocrinology
Frailty, diabetes increase fragility fracture risk
MDedge Endocrinology
Rise in HCV linked to OxyContin reformulation
MDedge Endocrinology
Michigan Medicine launches effort to make wellness a cultural norm
MDedge Endocrinology
Roux-en-Y achieves diabetes remission in majority of patients
MDedge Endocrinology
Clown-tox, tattooed immunity, and cingulum-bundle comedy
MDedge Endocrinology
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
MDedge Endocrinology
Hearing drills into patient impact of ACA legal challenge
MDedge Endocrinology
SGLT2 inhibitors morph into HF drugs
MDedge Endocrinology